Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case!
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please provide email or phone
Please provide email or phone

We do not show your email or contact info

Please accept our Terms & Conditions
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!


IMPORTANT - Your report is queued
It may take up to 12 hours to process your report.


Email us at support@safelyhq.com if you have questions.

Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Blood

Updated: October 2, 2023 8:01 PM
Hospira, Inc., a Pfizer company, is voluntarily recalling 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10mL vial; 1% Lidocaine HCl Injection, USP, 50 mg/5mL vial; and 2% Lidocaine HCl Injection, USP, 100 mg/5mL vial to the user level due to the potential presence of glass particulate matter. To... See More date, Hospira, Inc. has not received reports of any adverse events associated with this issue for these lots. The products were distributed nationwide to wholesalers/hospitals/institutions in the United States and Puerto Rico from October 13, 2022 through October 26, 2022.

The recalled products are:
- 4.2% Sodium Bicarbonate Injection, USP Glass ABBOJECT® Syringe, NDC: Carton 0409-5534-24. Case: 0409-5534-14. Lot: GJ5007. Expiration Date: 1AUG2024. Presentation: 5 mEq/10mL, (0.5 mEq/mL) Configuration/ Count: 1 vial and injector/ carton 10 cartons/ bundle Case pack 5 X 10- 10mL
- 1% Lidocaine HCl Injection, USP LIFESHIELD® Glass ABBOJECT® Syringe. NDC: Carton 0409-4904-11 Case 0409-4904-34. Lot: 42290DK. Expiration Date: 1JUN2024. Presentation: 50 mg/5mL (10 mg/mL). Configuration/ Count: 1 vial and injector/ carton 10 cartons/ bundle Case pack 5 X 10- 5mL
- 2% Lidocaine HCl Injection, USP LIFESHIELD® Glass ABBOJECT® Syringe. NDC: Carton 0409-4903-11 Case 0409-4903-34. Lot: GH6567. ExpirationDate: 1JUL2024. Presentation: 100 mg/5mL (20 mg/mL). Configuration/ Count: 1 vial and injector/ carton 10 cartons/ bundle Case pack 5 X 10- 5mL

There is an unlikely probability for serious adverse events, including death, should a patient receive an injectable product found to contain particulate matter identified as glass. Potential complications related to injection of visible and subvisible inert particles include inflammation of a vein, granuloma, and blockage of blood vessels or life-threatening blood clot events. The frequency and severity of these adverse events could vary depending upon a variety of factors including the size and number of particles in the drug product, patient comorbidities (such as age, compromised organ function), and presence or absence of vascular anomalies. The risk is reduced by the possibility of detection, as the label contains a clear statement directing the healthcare professional to visually inspect the product for particulate matter and discoloration prior to administration.

Sodium Bicarbonate Injection, USP is a sterile, nonpyrogenic, hypertonic solution of sodium bicarbonate (NaHCO3) in water for injection for administration by the intravenous route as an electrolyte replenisher and systemic alkalizer. It is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of hemoglobin and its breakdown products. It is also indicated in severe diarrhea which is often accompanied by a significant loss of bicarbonate.

Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of an antiarrhythmic agent administered intravenously by either direct injection or continuous infusion. It is available in various concentrations. It is administered intravenously or intramuscularly and is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery.

Wholesalers, hospitals, institutions, and doctors with an existing inventory of a lot which is being recalled should discontinue use, stop distribution and quarantine the product immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira, Inc.
Brand name: Hospira
Product recalled: 4.2% Sodium Bicarbonate Injection, USP, 1% Lidocaine HCl Injection, USP, and 2% Lidocaine HCl Injection, USP
Reason of the recall: Potential Presence of Glass Particulates
FDA Recall date: October 02, 2023

Source: fda.gov
See Less
303


We have been giving our dogs these treats, being advertised as a healthy alternative to raw hide. Our oldest female Chihuahua became ill on a Thursday evening. We contacted our vet and where advised to monitor her behavior and change her diet for twenty four hours. She... See More was vomiting and would not eat. Then diarrhea came. It was very bloody and had yellow in it with mucous. She was panting and trying to hide. The next morning her symptoms had become more severe. Our vet suggested we take her to an emergency hospital. Her kidney’s where failing and she was in diabetic shock. We where told with her age and symptoms she had a 5% chance to make it. She passed that morning. She was over 15 years old. She was part of our family. We trusted Dream Bones to be safe, do not be deceived!!! They are not safe and the FDA should start holding these companies accountable. There are no regulations on pet foods or treats! We should do better. Our furbabies deserve better standards. These bones poisoned all of our dogs and caused death in one. The company that markets these did treats need to be held accountable. Laws need to change and our pets need to be protected! | Symptoms: Diarrhea, Vomiting, Bloody Stool, Mucus in Stools See Less
6


My dog developed Inflammatory Bowel Disease after consuming Dream Bone products. His favorite treat was Dream Bone Sweat Potato bones. He would eat 1 to 2 bones daily. We have had to take him to the emergency vet twice for having a large amount of occult blood... See More in his stool. The emergency vet group (EVG) bills were close to $1000. | Symptoms: Bloody Stool See Less
668


Luffy (my dog) does not have any digestive problems and never has. He loves to have treats and I recently just bought him dream bones twists (peanut butter and chicken) I’ve gave him one after a long day and the next morning he had very bad diarrhea... See More and blood coming out with it. He continued to get mini episodes where he struggled to get any stool out and would was only able to push out very watery stool and blood. Later on he was beginning go to avoid any of his favorite foods and was beginning to walk in circles. He began to vomit anythung he had left in his stomach until he couldn’t throw up any more. He couldn’t get anything into his system and threw up anything that went in. He hasn’t gotten any better. | Symptoms: Diarrhea, Vomiting, Bloody Stool See Less
118


TruVision Health LLC is recalling several dietary supplement products because they contain the unapproved dietary ingredients hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine).  The products were distributed throughout the US, Canada, Australia, New Zealand, Germany, Ireland and England.

Hordenine is possibly unsafe when taken by mouth and might cause stimulating... See More side effects such as rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting or insomnia.  These adverse events are more likely to occur in sensitive sub-populations of people such as pregnant women and consumers with cardiovascular disease.  Currently, hordenine is not an approved dietary ingredient in dietary supplements.

Octodrine or DMHA (1,5-Dimethylhexylamine) appears to be similar to another stimulant called dimethylamylamine (DMAA), which was removed from the market in certain countries due to safety concerns. In animal studies, octodrine has been found to increase heart rate, myocardial contractility, and pain threshold.  Since no data exists on its metabolic pathway in humans, the use of octodrine during exercise is potentially dangerous.  DMHA is considered to be a substance that does not meet the statutory definition of a dietary ingredient and is an unsafe food additive.

The recalled products were packaged as capsules in blister packs and cardboard cartons or as stick packs in 30 count bags. The product bears the TruVision Health or the Truvy brand name. Lot numbers are located on the end flap of the carton or the back of the bag.
Products affected are:
SKU: 1004, Description: truCONTROL 60 Count, Lot: 13580
SKU: 1005, Description: TruControl 7 Day Trifold, Lot: WKW72353
SKU: 1006, Description: reFORM, Lot: 34159
SKU: 1010, Description: truControl with Dynamine 60 ct, Lot: WK65081
SKU: 8402, Description: TruWeight and Energy Gen 2+ 60 Count, Lot: WK71567
SKU: 8403, Description: TruWeight and Energy Gen 2+ Trifold, Lot: 25173
SKU: 10000, Description: Truvy 30-Day Experience Kit, Lot: 39643/42825
SKU: 10001, Description: Truvy 7-Day Experience Kit, Lot: 41404
SKU: 10002, Description: Truvy Boost 30-Day Experience Kit, Lot: 13993
SKU: 10003, Description: TruBoost 7 Day Experience Kit, Lot: 13985
SKU: 12000, Description: TruBoost Drink - Citrine Spark, Lot: PM17921F1
SKU: 12001, Description: TruBoost Drink - Ruby Rev, Lot: PM18821F1

Consumers who have purchased these products should stop using them immediately and they are urged to return them to TruVision Health LLC for a full refund (return shipping is paid by the consumer), an exchange, or they may discard the product.

This recall was initiated after an FDA inspection determined that the products were adulterated.

Some consumers of these products have reported experiencing chest pain, chills, diarrhea, dizziness/lightheadedness, fatigue, headache, high blood pressure, high heart rate, jitters, nausea, nervousness, rash, stomach pain or upset, sweating and vomiting.

In case you experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: TruVision Health
Brand name: Truvy TruVision reFORM
Product recalled: Various Dietary Supplement Capsules
Reason of the recall: Unapproved Hordenine and octodrine/DMHA (1,5-dimethylhexylamine)
FDA Recall date: April 27, 2023

Source: fda.gov
See Less
303


Gear Isle is voluntarily recalling several Male enhancement capsules (Brands: Pro Power Knight Plus, NUX, Dynamite Super) to the consumer level. FDA analysis has found the products to be tainted with sildenafil and tadalafil. Sildenafil and tadalafil are ingredients known as Phosphodiesterase Inhibitors (PDE-5) inhibitors found in... See More FDA-approved products for the treatment of male erectile dysfunction. The presence of sildenafil and tadalafil in these products renders them unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall. The products were distributed Nationwide in the USA via internet sales via the website gearisle.com. To date, Gear Isle has not received any reports of illness or adverse events related to this recall.

The recalled products are:
- Pro Power Knight Plus Capsule, 2550 mg 1-count blister card, UPC: 4 9492290522 0, Expiration date: 06/2026
- NUX Male Enhancement Capsule, 1-count blister card, UPC: 6 0157751236 3, Lot # RO 927996, Expiration date: 12/25/2024
- DYNAMITE SUPER Capsule 58,000 mg 1-count blister card, UPC: 6 7579937602 7, Lot# OMS760-B, Expiration date: 12/2025.

These products are marketed as dietary supplements for male sexual enhancement and are packaged in 1-count blister cards.

Consumption of products with undeclared sildenafil and tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life-threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population who are most likely to use these products, adult males who use nitrates for cardiac conditions are most at risk from these products.

In case you experience harm from these products, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Gadget Island, Inc.
Brand name: Pro Power Knight Plus, NUX, Dynamite Super
Product recalled: Male enhancement capsules
Reason of the recall: Product contains undeclared tadalafil and sildenafil
FDA Recall date: April 26, 2023

Source: fda.gov
See Less
303


I placed an order worth 100 dollars of garden planters and only received 2 pairs of ugly black socks, this is absolutely theft. bloody people scamming others and getting away with it.

I'm in Berlin Borough See Less
2.8K


I keep getting this stuff every week. I only wanted to try it for a month. The one for blood sugar. I don’t want the keto cleanse at all. See Less
1.4K


I just told you i received an unordered package  with some kind of blood sugzrpills fromPrextige in Fushing NY for 89.95. i have no intention of payingfor it See Less
2.8K


Last 30 days